• 1. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 2. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Introduction to 3-(3-Fluoro-4-methylphenyl)aniline hydrochloride (CAS No. 1352318-32-1) in Modern Chemical and Pharmaceutical Research

3-(3-Fluoro-4-methylphenyl)aniline hydrochloride, identified by the Chemical Abstracts Service Number (CAS No.) 1352318-32-1, is a significant compound in the realm of chemical and pharmaceutical research. This organohalogen derivative, featuring a fluoro-substituted aromatic ring and an aniline moiety, has garnered attention due to its versatile applications in medicinal chemistry and drug development. The presence of both fluorine and methyl groups imparts unique electronic and steric properties, making it a valuable scaffold for designing novel therapeutic agents.

The compound’s structure, comprising a fluoro-4-methylphenyl group attached to an aniline backbone, is central to its chemical behavior and biological activity. The fluorine atom, known for its ability to modulate metabolic stability and binding affinity, plays a crucial role in enhancing the pharmacokinetic profiles of drugs. In contrast, the methyl group contributes to steric hindrance, influencing molecular interactions with biological targets. This combination makes 3-(3-Fluoro-4-methylphenyl)aniline hydrochloride a promising candidate for further exploration in drug discovery.

Recent advancements in pharmaceutical research have highlighted the importance of fluorinated aromatic compounds in developing next-generation therapeutics. Studies have demonstrated that the introduction of fluorine into phenyl rings can significantly improve the bioavailability and efficacy of small-molecule drugs. For instance, fluorinated anilines have been widely used in the synthesis of kinase inhibitors, antiviral agents, and anti-inflammatory medications. The hydrochloride salt form of 3-(3-Fluoro-4-methylphenyl)aniline hydrochloride enhances its solubility and stability, making it more suitable for formulation into pharmaceutical products.

The compound’s potential applications extend beyond traditional drug development. Researchers are exploring its utility in materials science, particularly in the design of advanced polymers and liquid crystals. The fluoro-substituted aromatic ring can act as a building block for creating materials with enhanced thermal stability and chemical resistance. Additionally, the aniline group provides a site for further functionalization, enabling the synthesis of complex polymers with tailored properties.

In the context of medicinal chemistry, 3-(3-Fluoro-4-methylphenyl)aniline hydrochloride has been investigated for its role as an intermediate in synthesizing bioactive molecules. Its structural features allow for easy modification at multiple positions, facilitating the creation of derivatives with improved pharmacological properties. For example, researchers have modified this compound to develop novel antitumor agents that target specific enzymes involved in cancer cell proliferation. The fluoro group’s ability to enhance binding affinity has been particularly useful in designing highly selective inhibitors.

The synthesis of 3-(3-Fluoro-4-methylphenyl)aniline hydrochloride involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies, such as palladium-catalyzed cross-coupling reactions and nucleophilic aromatic substitutions, have been employed to achieve high yields and purity. These techniques ensure that the final product meets the stringent requirements of pharmaceutical applications.

From a regulatory perspective, the production and handling of 3-(3-Fluoro-4-methylphenyl)aniline hydrochloride must adhere to Good Manufacturing Practices (GMP) to ensure safety and quality. Manufacturers must implement rigorous quality control measures at every stage of production to minimize impurities and ensure consistency across batches. This is essential for maintaining the compound’s efficacy in pharmaceutical formulations.

The growing interest in fluorinated compounds underscores their importance in modern drug discovery. 3-(3-Fluoro-4-methylphenyl)aniline hydrochloride exemplifies how structural modifications can lead to compounds with enhanced therapeutic potential. As research continues to uncover new applications for this compound, it is likely to play an increasingly significant role in both academic and industrial settings.

In conclusion, 3-(3-Fluoro-4-methylphenyl)aniline hydrochloride (CAS No. 1352318-32-1) is a versatile compound with broad applications in chemical synthesis and pharmaceutical development. Its unique structural features make it a valuable tool for researchers seeking to develop novel therapeutics and advanced materials. As scientific understanding progresses, this compound is expected to contribute significantly to innovation across multiple disciplines.

• 321-61-9([1,1'-Biphenyl]-4-amine,2'-fluoro-)
• 3803-22-3(Benzenamine, 4-fluoro-3-methyl-, hydrochloride)
• 1210215-22-7(3'-Fluoro-1,1'-biphenyl-3-amine hydrochloride)
• 1187386-07-7(3-(3-Fluoro-4-methylphenyl)aniline)
• 1355247-93-6(4-(3-fluoro-4-methylphenyl)aniline)
• 160521-67-5(2',4'-difluoro-3-biphenylamine)
• 176032-77-2([1,1'-Biphenyl]-3-amine, 2'-fluoro-)
• 103977-88-4(4-fluoro-3-phenylaniline)
• 1183774-59-5(4-(4-fluoro-3-methylphenyl)aniline)
• 400751-05-5(3-(3-fluorophenyl)aniline)